Clinical significance of hyaluronan levels and its pro-osteogenic effect on mesenchymal stromal cells in myelodysplastic syndromes
Abstract Background Hyaluronan (HA), a major component of the extracellular matrix, has been proven to play a crucial role in tumor progression. However, it remains unknown whether HA exerts any effects in myelodysplastic syndromes (MDS). Methods A total of 82 patients with MDS and 28 healthy donors...
| Published in: | Journal of Translational Medicine |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
BMC
2018-08-01
|
| Subjects: | |
| Online Access: | http://link.springer.com/article/10.1186/s12967-018-1614-4 |
